GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease
Incyte Corporation
Incyte Corporation
Astex Pharmaceuticals, Inc.
Kyowa Kirin Co., Ltd.
Takeda
Pfizer
Takeda
Teva Branded Pharmaceutical Products R&D, Inc.
Gilead Sciences
Novartis
Novartis
Novartis
Eli Lilly and Company
Dong-A ST Co., Ltd.
Novartis
Celldex Therapeutics
Erimos Pharmaceuticals
Merck Sharp & Dohme LLC
Exelixis
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Teva Branded Pharmaceutical Products R&D, Inc.
Ariad Pharmaceuticals
Texas Oncology Cancer Center
Bristol-Myers Squibb
The Emmes Company, LLC
Agenus Inc.
Novartis
Novartis
Novartis